Cytokine profile associated with selective removal of natural anti-αGal antibodies in a sepsis model in Gal-KO mice

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Biochemistry (Moscow)

• Publication date

  2017-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1134/S0006297917020122PMID 28320304
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Generic Mechanism for Enhanced Cytokine Signaling via Cytokine-Neutralizing Antibodies

  2016cited by this paper
• Hypotheses of the origin of natural antibodies: A glycobiologist’s opinion

  2015cited by this paper
• CXCL1 Contributes to Host Defense in Polymicrobial Sepsis via Modulating T Cell and Neutrophil Functions

  2014cited by this paper
• Significance of the Evolutionary α1,3-Galactosyltransferase (GGTA1) Gene Inactivation in Preventing Extinction of Apes and Old World Monkeys

  2014cited by this paper
• Increased severity of respiratory infections associated with elevated anti-LPS IgG2 which inhibits serum bactericidal killing

  2014cited by this paper
• Inflammasome activation plays an important role in the development of spontaneous colitis

  2014cited by this paper
• Dengue Viruses Are Enhanced by Distinct Populations of Serotype Cross-Reactive Antibodies in Human Immune Sera

  2014cited by this paper
• Differences between murine and human sepsis.

  2014cited by this paper
• The circulating level of MMP-9 and its ratio to TIMP-1 as a predictor of severity in patients with community-acquired pneumonia.

  2013cited by this paper
• Role of Leptin-Mediated Colonic Inflammation in Defense against Clostridium difficile Colitis

  2013cited by this paper
• Leptin and Mucosal Immunity

  2012cited by this paper
• Natural antibodies in normal human serum inhibit Staphylococcus aureus capsular polysaccharide vaccine efficacy.

  2012cited by this paper
• CXCL1-deficient mice are highly sensitive to pseudomonas aeruginosa but not herpes simplex virus type 1 corneal infection.

  2012cited by this paper
• MMP-1 drives immunopathology in human tuberculosis and transgenic mice.

  2011cited by this paper
• CXCL1 Regulates Pulmonary Host Defense to Klebsiella Infection via CXCL2, CXCL5, NF-κB, and MAPKs

  2010cited by this paper
• Genetic Variation in Innate Immunity Pathways and Their Potential Contribution to the SIRS/CARS Debate: Evidence from Human Studies and Animal Models

  2010cited by this paper
• Cytokine/Antibody complexes: an emerging class of immunostimulants.

  2009cited by this paper
• Matrix metalloproteinases and their inhibitors: promising novel biomarkers in severe sepsis?

  2009cited by this paper
• Immunodesign of experimental sepsis by cecal ligation and puncture

  2008cited by this paper
• Leptin improves pulmonary bacterial clearance and survival in ob/ob mice during pneumococcal pneumonia

  2007cited by this paper
• LEPTIN AND HOST DEFENSE AGAINST GRAM-POSITIVE AND GRAM-NEGATIVE PNEUMONIA IN MICE

  2006cited by this paper
• A rapid, simple, and humane method for submandibular bleeding of mice using a lancet

  2005cited by this paper
• Serum Levels of the Homeostatic B Cell Chemokine, CXCL13, Are Elevated During HIV Infection

  2005cited by this paper
• Removal of anti-Galalpha1,3Gal xenoantibodies with an injectable polymer.

  2002cited by this paper
• Removal of anti-Galα1,3Gal xenoantibodies with an injectable polymer

  2002cited by this paper
• Plasma cytokine response in mice with bacterial infection.

  2000cited by this paper
• Comparative analysis of three genetic modifications designed to inhibit human serum‐mediated cytolysis

  1999cited by this paper
• Positional cloning of the mouse obese gene and its human homologue

  1994cited by this paper
• Human natural anti-Gal IgG regulates alternative complement pathway activation on bacterial surfaces.

  1992cited by this paper
• A unique natural human IgG antibody with anti-alpha-galactosyl specificity

  1984cited by this paper

• Removal of natural anti-αGal antibodies elicits protective immunity against Gram-negative bacterial infections

  2023cites this paper
• Poly-L-Lysine-Based αGal-Glycoconjugates for Treating Anti-αGal IgE-Mediated Diseases

  2022cites this paper
• Gut Microbiota Abrogates Anti-α-Gal IgA Response in Lungs and Protects against Experimental Aspergillus Infection in Poultry

  2020cites this paper
• α-Gal-Based Vaccines: Advances, Opportunities, and Perspectives.

  2020cites this paper